Neurogene Inc.
NGNE
$36.14
$0.511.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -111.11M | -98.64M | -90.35M | -85.13M | -84.39M |
| Total Depreciation and Amortization | 3.24M | 3.18M | 3.09M | 3.10M | 3.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.60M | 10.08M | 9.82M | 8.76M | 8.11M |
| Change in Net Operating Assets | 5.45M | 2.86M | 268.00K | -3.98M | -148.00K |
| Cash from Operations | -86.82M | -82.52M | -77.17M | -77.24M | -73.30M |
| Capital Expenditure | -890.00K | -684.00K | -1.18M | -1.17M | -1.21M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 104.83M | 105.97M | 15.19M | -117.05M | -167.97M |
| Cash from Investing | 103.94M | 105.29M | 14.00M | -118.22M | -169.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -43.00K | -52.00K | -61.00K | -55.00K | -54.00K |
| Issuance of Common Stock | 36.85M | 30.91M | 30.73M | 200.05M | 190.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -258.00K | -241.00K | -241.00K | -166.00K | 0.00 |
| Cash from Financing | 36.55M | 30.62M | 30.43M | 199.83M | 190.25M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.67M | 53.39M | -32.74M | 4.37M | -52.22M |